Möchten Sie immer auf dem neuesten Stand bleiben?

CARMEL, Ind., Aug. 04, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic...

JACKSONVILLE, Fla., July 30, 2026 (GLOBE NEWSWIRE) -- MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients...

CARMEL, Ind., July 28, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing...

Dublin, July 22, 2026 (GLOBE NEWSWIRE) -- The "Medical Device Collaboration and Licensing Deals 2016-2026" has been added to ResearchAndMarkets.com's offering.This report provides a comprehensive...

HeadStrait Labs announced a $350,000 lead investment from the Richard King Mellon Foundation. The total amount raised to date is more than $680,000.

Nanox Announces First Quarter 2026 Financial Results and Updates Nanox Announces First Quarter 2026 Financial Results and Provides Business Updates

Regulatory Milestone Advances First-in-Class Non-Invasive Technology Targeting a Multi-Billion-Dollar Orthopedic Infection Market Clinical Site Activation Across Leading Centers in the U.S. and...

Thanks to the support of the Linda and Mike Mussallem Foundation, Octane has launched the Octane Mussallem Cardiovascular Accelerator.

nCAP Medical Announces Publication of Positive RCT Results Demonstrating NeuroCuple®

In a capital-constrained market with selective investment, Keiretsu Forum-MST is demonstrating how discipline produces investable companies.